|
Market Closed -
Nasdaq
21:00:00 20/07/2026 BST
|
5-day change
|
1st Jan Change
|
|
2.020 USD
|
+24.69%
|
 |
+12.85%
|
+46.38%
|
|
07-20 |
Neuronetics Names Nir Naor as CFO
|
MT
| |
07-20 |
Neuronetics, Inc. Announces Management Changes
|
CI
| |
07-20 |
Neuronetics, Inc. Announces Appointment of Nir Naor to Chief Financial Officer, Effective July 23, 2026
|
CI
| |
07-20 |
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes
|
AQ
| |
07-07 |
Neuronetics to Participate in a Panel Discussion at B. Riley Securities Mind, Muscle and Vision Summit on July 16, 2026
|
AQ
| |
07-06 |
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026
|
AQ
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Dynamic Index
|
CI
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E Index
|
CI
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small Cap Completeness Index
|
CI
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 Index
|
CI
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 Index
|
CI
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Index
|
CI
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E Growth Benchmark
|
CI
| |
06-29 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 Growth Benchmark
|
CI
| |
06-28 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small Cap Comp Growth Benchmark
|
CI
| |
06-28 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 Growth Benchmark
|
CI
| |
06-28 |
Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Growth Benchmark
|
CI
| |
06-23 |
Neuronetics, Inc. Announces Appointment of Cory Anderson to Executive Vice President, Effective July 1, 2026
|
CI
| |
06-02 |
Neuronetics Appoints Robert Greene as Senior Vice President Sales
|
AQ
| |
06-02 |
Neuronetics, Inc. Announces Appointment of Robert Greene to Senior Vice President Sales, Effective June 1, 2026
|
CI
| |
06-02 |
Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
|
GL
| |
05-22 |
Neuronetics, Inc. Appoints Francis X. Brown III as Interim Principal Financial Officer, Effective May 5, 2026
|
CI
| |
05-22 |
Neuronetics, Inc. Appoints Francis X. Brown III as Accounting Officer, Effective as of May 5, 2026
|
CI
| |
05-14 |
Neuronetics and Ant Neuro announce strategic collaboration to integrate neuronavigation with Neurostar TMS treatment
|
RE
| |
05-14 |
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
|
GL
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
